Hikma And Reddy’s Tell Supreme Court To Throw Out Vascepa Appeal

Amarin Has Petitioned Supreme Court For Certiorari Review

Certiorari review of a Federal Circuit decision invalidating Vascepa patents “is not warranted,” Hikma and Dr Reddy’s Laboratories have argued, claiming that the premise of originator Amarin’s petition to the US Supreme Court is “false.”

US-Supreme-Court_V2_1200
The Federal Circuit and district court decisions are “correct and do not conflict with any precedent,” Hikma and Reddy's argue • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin